using a 5F MAK access kit. A 7 F
balloon tipped catheter was introduced via the venous sheath, the balloon was inflated and the catheter was advanced through the
right heart chambers into the
pulmonary capillary wedge position. Right sided pressures were obtained and
cardiac output was measured using thermodilution. Coronary angiography is a diagnostic procedure that allows visualization of the coronary vessels. Fluoroscopy is used to visualize the lumens of the arteries as a 2-D projection. Should these arteries show narrowing or blockage, then techniques exist to open these arteries.
Percutaneous coronary intervention is a blanket term that involves the use of mechanical stents, balloons, etc. to increase blood flow to previously blocked (or occluded) vessels. Measuring pressures in the heart is also an important aspect of catheterization. The catheters are fluid filled conduits that can transmit pressures to outside the body to
pressure transducers. This allows measuring pressure in any part of the heart that a catheter can be maneuvered into. Measuring blood flow is also possible through several methods. Most commonly, flows are estimated using the
Fick principle and thermodilution. These methods have drawbacks, but give invasive estimations of the cardiac output, which can be used to make clinical decisions (e.g.,
cardiogenic shock,
heart failure) to improve the person's condition. Cardiac catheterization can be used as part of a therapeutic regimen to improve outcomes for survivors of out-of-hospital cardiac arrest. Cardiac catheterization often requires the use of
fluoroscopy to visualize the path of the catheter as it enters the heart or as it enters the coronary arteries. The coronary arteries are known as "epicardial vessels" as they are located in the epicardium, the outermost layer of the heart. The use of fluoroscopy requires radiopaque contrast, which in rare cases can lead to contrast-induced kidney injury (see
Contrast-induced nephropathy). People are constantly exposed to low doses of
ionizing radiation during procedures. Ideal table positioning between the x-ray source and receiver, and
radiation monitoring via
thermoluminescent dosimetry, are two main ways of reducing a person's exposure to radiation. At this point, a catheter is guided over the wire into the ascending aorta, where it can be maneuvered into the coronary arteries through the coronary ostia. In this position, the interventional cardiologist can inject contrast and visualize the flow through the vessel. If necessary, the physician can utilize percutaneous coronary intervention techniques, including the use of a
stent (either bare-metal or
drug-eluting) to open the blocked vessel and restore appropriate blood flow. In general, occlusions greater than 70% of the width of the vessel lumen are thought to require intervention. However, in cases where multiple vessels are blocked (so-called "three-vessel disease"), the interventional cardiologist may opt instead to refer the patient to a cardiothoracic surgeon for coronary artery bypass graft (CABG; see
Coronary artery bypass surgery) surgery.
Right heart catheterization (RHC) Right heart catheterization (RHC) allows the physician to determine the pressures within the heart (intracardiac pressures). The heart is most often accessed via the internal jugular or femoral vein; arteries are not used. Values are commonly obtained for the right atrium, right ventricle, pulmonary artery, and pulmonary capillary "wedge" pressures. Right heart catheterizations also allow the physician to estimate the cardiac output, the amount of blood that flows from the heart each minute, and the cardiac index, a hemodynamic parameter that relates the cardiac output to a patient's body size.
Determination of cardiac output can be done by releasing a small amount of saline solution (either chilled or at room temperature) in one area of the heart and measuring the change in blood temperature over time in another area of the heart. Right heart catheterization is often done for
pulmonary hypertension,
heart failure, and
cardiogenic shock. The pulmonary artery catheter can be placed, used, and removed, or it can be placed and left in place for continuous monitoring. The latter can be done an
intensive care unit (ICU) to permit frequent measurement of the hemodynamic parameters in response to interventions. Parameters obtainable from a right heart catheterization: • Right atrial pressure • Right ventricular pressure • Pulmonary artery pressure • Pulmonary capillary wedge pressure • Systemic vascular resistance • Pulmonary vascular resistance • Cardiac output • Blood oxygenation
Coronary catheterization Coronary catheterization is an invasive process and comes with risks that include stroke, heart attack, and death. Like any procedure, the benefits should outweigh the risks and so this procedure is reserved for those with symptoms of serious heart diseases and is never used for screening purposes. Other, non-invasive tests are better used when the diagnosis or certainty of the diagnosis is not as clear. Indications for cardiac catheterization include the following: •
Acute coronary syndromes: ST elevation MI (STEMI), non-ST Elevation MI (NSTEMI), and unstable angina • Evaluation of
coronary artery disease as indicated by • Abnormal stress test • As part of the pre-op evaluation for other cardiac procedures (e.g., valve replacement) as
coronary artery bypass grafting may be done at the same time • Risk stratification for high cardiac risk surgeries (e.g.,
endovascular aneurysm repair) • Persistent chest pain despite medical therapy thought to be cardiac in origin • New-onset unexplained heart failure • Survival of
sudden cardiac death or dangerous cardiac arrhythmias • Workup of suspected Prinzmetal angina (
coronary vasospasm) Right heart catheterization, along with
pulmonary function testing and other testing should be done to confirm
pulmonary hypertension prior to having
vasoactive pharmacologic treatments approved and initiated. • to measure intracardiac and
intravascular blood pressures • to take tissue samples for
biopsy • to inject various agents for measuring blood flow in the heart; also to detect and quantify the presence of an intracardiac
shunt • to inject
contrast agents in order to study the shape of the heart vessels and chambers and how they change as the heart beats
Pacemakers and defibrillators s of a pacemaker with normally located leads in the right atrium (white arrow) and right ventricle (black arrowhead), respectively. Placement of internal
pacemakers and
defibrillators are done through catheterization as well. An exception to this is placement of electrodes on the outer surface of the heart (called epicardial electrodes). Otherwise, electrodes are placed through the venous system into the heart and left there permanently. Typically, these devices are placed in the left upper chest and enter the left
subclavian vein and electrodes are placed in the right atrium, right ventricle, and coronary sinus (for the left ventricle stimulation).
Valve assessment Echocardiography is a non-invasive method to evaluate the heart valves. However, sometimes the valve pressure gradients need to be measured directly because echo is equivocal for the severity of valve disease. Invasive assessment of the valve can be done with catheterization by placing a catheter across the valve and measuring the pressures simultaneously on each side of the valve to obtain the pressure gradient. In conjunction with a right heart catheterization, the valve area can be estimated. For example, in
aortic valve area calculation the Gorlin equation can be used to calculate the area if the cardiac output, pressure gradient, systolic period, and heart rate are known.
Pulmonary angiography Evaluation of the blood flow to the lungs can be done invasively through catheterization. Contrast is injected into the pulmonary trunk, left or right pulmonary artery, or segment of the pulmonary artery.
Shunt evaluation Cardiac shunts can be evaluated through catheterization. Using oxygen as a marker, the
oxygen saturation of blood can be sampled at various locations in and around the heart. For example, a left-to-right
atrial septal defect will show a marked increase in oxygen saturation in the right atrium, ventricle, and pulmonary artery as compared to the
mixed venous oxygen saturation from the oxygenated blood from the lungs mixing into the venous return to the heart. Utilizing the
Fick principle, the ratio of blood flow in the lungs (Qp) and system circulations (Qs) can calculate the Qp:Qs ratio. Elevation of the Qp:Qs ratio above 1.5 to 2.0 suggests that there is a hemodynamically significant left-to-right shunt (such that the blood flow through the lungs is 1.5 to 2.0 times more than the systemic circulation). This ratio can be evaluated non-invasively with
echocardiography too, however. A "shunt run" is often done when evaluating for a shunt by taking blood samples from
superior vena cava (SVC),
inferior vena cava (IVC),
right atrium,
right ventricle,
pulmonary artery, and system arterial. Abrupt increases in oxygen saturation support a left-to-right shunt and lower than normal systemic arterial oxygen saturation supports a right-to-left shunt. Samples from the SVC & IVC are used to calculate
mixed venous oxygen saturation.
Ventriculography By injecting contrast into the left ventricle, the outline of the ventricle can be measured in both systole and diastole to estimate the
ejection fraction (a marker of heart function). Due to the high contrast volumes and injection pressures, this is often not performed unless other, non-invasive methods are not acceptable, not possible, or conflicting.
Percutaneous or transcutaneous aortic valve replacement (TAVR) Advancements in cardiac catheterization have permitted replacement of heart valves by means of blood vessels. This method allows
valve replacement without
open heart surgery and can be performed on people who are high-risk for such a surgery.
Balloon septostomy Catheterization can also be used to perform
balloon septostomy, which is the widening of a
foramen ovale,
patent foramen ovale (
PFO), or
atrial septal defect (
ASD) using a
balloon catheter. This can be done in certain congenital heart diseases in which the mechanical shunting is required to sustain life such as in
transposition of the great vessels.
Alcohol septal ablation (ASA) Hypertrophic cardiomyopathy is a disease in which the myocardium is thickened and can cause blood flow obstruction. If hemodynamically significant, this excess muscle can be removed to improve blood flow. Surgically, this can be done with
septal myectomy. However, it can be done through catheterization and by injecting
ethanol to destroy the tissue in an
alcohol septal ablation. This is done by selected an appropriate septal artery supplying the intended area and, essentially, causing a localized, controlled
myocardial infarction of the area with ethanol. ==Complications==